IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 156 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $554,000 | -9.5% | 53,485 | +0.8% | 0.02% | +17.6% |
| Q2 2022 | $612,000 | -27.7% | 53,036 | -21.2% | 0.02% | -29.2% |
| Q1 2022 | $846,000 | +7.8% | 67,282 | 0.0% | 0.02% | +20.0% |
| Q4 2021 | $785,000 | -12.7% | 67,282 | -2.3% | 0.02% | -13.0% |
| Q3 2021 | $899,000 | -45.4% | 68,853 | -46.2% | 0.02% | -53.1% |
| Q2 2021 | $1,646,000 | +4.9% | 127,867 | -8.9% | 0.05% | +22.5% |
| Q1 2021 | $1,569,000 | +22314.3% | 140,338 | +26229.8% | 0.04% | – |
| Q1 2019 | $7,000 | -99.5% | 533 | -99.4% | 0.00% | -100.0% |
| Q4 2017 | $1,412,000 | +149.9% | 94,200 | +215.1% | 0.11% | +113.2% |
| Q2 2017 | $565,000 | -5.2% | 29,900 | -14.4% | 0.05% | -7.0% |
| Q1 2017 | $596,000 | +69.3% | 34,937 | +51.9% | 0.06% | +32.6% |
| Q4 2016 | $352,000 | -51.6% | 23,005 | -49.7% | 0.04% | -43.4% |
| Q3 2016 | $727,000 | – | 45,758 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |